Clinical trial
Abiliti™ Treatment in Obese Subjects: A Randomized Post-Market Surveillance Multicenter Study
NCT01448785 is registered in ClinicalTrials.gov with IntraPace, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Abiliti™ Treatment in Obese Subjects: A Randomized Post-Market Surveillance Multicenter Study
- Lead sponsor
- IntraPace, Inc
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2011
- Completion date
- January 31, 2015
- Enrollment
- 165 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
morbid obesity, obesity